Table 2.
Abnormal plaque-like gephyrin immunoreactivity
Cases | Normal | Abnormal |
---|---|---|
Control | 13 | 1 |
AD | 2 | 15 |
PD | 3 | 0 |
CBD | 3 | 0 |
FTD | 3 | 0 |
Abnormal plaque-like gephyrin immunoreactivity
Cases | Normal | Abnormal |
---|---|---|
Control | 13 | 1 |
AD | 2 | 15 |
PD | 3 | 0 |
CBD | 3 | 0 |
FTD | 3 | 0 |